Children’s Research Institute | Academic Annual Report 2017-2018

Innovation Through Collaboration

Financials

Research Funding Data

Research Funding by Center Total Percent
Cancer and Immunology $8,483,884.53 11.65%
Center for Translational Science $23,903,207.47 32.82%
Genetics $15,340,472.32 21.06%
Neuroscience $14,602,919.62 20.05%
Sheikh Zayed $10,502,823.06 14.42%
Total $72,833,307.00 100.00%
Research Funding by Sponsor Total Percent
NIH $41,424,476.09 56.88%
HRSA $3,013,738.45 4.14%
DOD $2,298,517.33 3.16%
Other Federal $1,487,867.69 2.04%
Non-Federal (Includes Donations) $19,685,376.74 27.03%
Sheikh Zayed (Includes Donations) $3,516,084.00 4.83%
Internal $1,407,246.70 1.93%
Total $72,833,307.00 100.00%
Fiscal Year Dollars in Millions
FY08 $24.39
FY09 $31.17
FY10 $38.40
FY11 $39.20
FY12 $39.02
FY13 $41.15
FY14 $39.95
FY15 $39.07
FY16 $39.12
FY17 $41.42
10 Year NIH Funding Trend
Funded by the Food and Drug Administration (FDA), the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is a partnership of the Sheikh Zayed Institute for Pediatric Surgical Innovation and the A. James Clark School of Engineering at the University of Maryland
Innovation Spotlight

Meeting the Medical Device Needs of Pediatric Patients

Previous Read
Financials

Intellectual Property Summary